Alphamab Oncology — Audit Report / Information 2019

Nov 17, 2019

PHIP

	Alphamab Oncology - B
	YOU SHOULD READ THE WARNING IN THE DOCUMENT.

 

►	WARNING
►	IMPORTANT
►	EXPECTED TIMETABLE
►	CONTENTS
►	SUMMARY
►	DEFINITIONS
►	GLOSSARY OF TECHNICAL TERMS
►	FORWARD-LOOKING STATEMENTS
►	RISK FACTORS
►	WAIVERS FROM STRICT COMPLIANCE WITH THE LISTING RULES AND EXEMPTIONS FROM COMPLIANCE WITH THE COMPANIES (WINDING UP AND MISCELLANEOUS PROVISIONS) ORDINANCE
►	INFORMATION ABOUT THIS DOCUMENT AND THE [REDACTED]
►	DIRECTORS AND PARTIES INVOLVED IN THE [REDACTED]
►	CORPORATE INFORMATION
►	INDUSTRY OVERVIEW
►	REGULATIONS
►	HISTORY, REORGANIZATION AND CORPORATE STRUCTURE
►	BUSINESS
►	DIRECTORS AND SENIOR MANAGEMENT
►	RELATIONSHIP WITH CONTROLLING SHAREHOLDERS
►	CONNECTED TRANSACTIONS
►	SUBSTANTIAL SHAREHOLDERS
►	SHARE CAPITAL
►	FINANCIAL INFORMATION
►	FUTURE PLANS AND USE OF [REDACTED]
►	[REDACTED]
►	STRUCTURE OF THE [REDACTED]
►	HOW TO APPLY FOR [REDACTED]
►	APPENDIX I - ACCOUNTANTS' REPORT
►	APPENDIX II - UNAUDITED PRO FORMA FINANCIAL INFORMATION
►	APPENDIX III - PROPERTY VALUATION REPORT
►	APPENDIX IV - SUMMARY OF THE CONSTITUTION OF THE COMPANY AND CAYMAN ISLANDS COMPANY LAW
►	APPENDIX V - STATUTORY AND GENERAL INFORMATION
►	APPENDIX VI - DOCUMENTS DELIVERED TO THE REGISTRAR OF COMPANIES AND AVAILABLE FOR INSPECTION